Oragenics Inc logo

Oragenics Inc

AMEX:OGEN (USA)  
$ 1.07 +0.0199 (+1.9%) 11:09 PM EST
At Loss
P/B:
2.09
Volume:
15.63K
Avg Vol (2M):
57.16K
Also Trade In:
Volume:
15.63K
At Loss
Avg Vol (2M):
57.16K

Business Description

Description
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.
Name Current Vs Industry Vs History
Cash-To-Debt 10.79
Equity-to-Asset 0.64
Debt-to-Equity 0.1
Debt-to-EBITDA -0.02
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 54.39
9-Day RSI 41.97
14-Day RSI 36.27
6-1 Month Momentum % -65.17
12-1 Month Momentum % -49.81

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.15
Quick Ratio 2.15
Cash Ratio 1.94

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -26.3
Shareholder Yield % 4.76
Name Current Vs Industry Vs History
ROE % -257.08
ROA % -214.2
ROIC % -1383.09
ROC (Joel Greenblatt) % -1743.74
ROCE % -254.64